SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-030019
Filing Date
2024-02-09
Accepted
2024-02-09 16:17:05
Documents
2
Group Members
HARBOURVEST PARTNERS, LLCHVST-TOPE LLCSMRS-TOPE LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d764529dsc13ga.htm SC 13G/A 89311
2 EX-99.1 d764529dex991.htm EX-99.1 7073
  Complete submission text file 0001193125-24-030019.txt   98110
Mailing Address HARBOURVEST PARTNERS, LLC ONE FINANCIAL CENTER, 44TH FLOOR BOSTON MA 02111
Business Address HARBOURVEST PARTNERS, LLC ONE FINANCIAL CENTER, 44TH FLOOR BOSTON MA 02111 617-348-3707
HarbourVest Partners L.P. (Filed by) CIK: 0001608086 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141
Business Address 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141 (617) 949-4360
Omega Therapeutics, Inc. (Subject) CIK: 0001850838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92749 | Film No.: 24615191
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)